- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Sexually Transmitted Diseases
Volume 2013 (2013), Article ID 750415, 6 pages
The Epidemiology of Herpes Simplex Virus Type-2 Infection among Pregnant Women in Rural Mysore Taluk, India
1Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA 98195, USA
2Department of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International University, 11200 SW 8 Street, HLS 390W2, Miami, FL 33199, USA
3Public Health Research Institute of India, Mysore, Karnataka 560020, India
4Department of Health Promotion and Disease Prevention, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, FL 33199, USA
5Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
Received 28 July 2013; Accepted 25 September 2013
Academic Editor: Consuelo Beck-Sagué
Copyright © 2013 Aaron F. Bochner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Objectives. To assess the prevalence and determinants of herpes simplex virus type 2 (HSV-2) infections among pregnant women attending mobile antenatal health clinic in rural villages in Mysore Taluk, India. Methods. Between January and September 2009, 487 women from 52 villages participated in this study. Each participant consented to provide a blood sample for HSV-2 and HIV testing and underwent an interviewer-administered questionnaire. Results. HSV-2 prevalence was 6.7% (95% confidence interval (CI) 4.4–9.0), and one woman tested positive for HIV. The median age of women was 20 years and 99% of women reported having a single lifetime sex partner. Women whose sex partner traveled away from home had 2.68 (CI: 1.13–6.34) times the odds of being HSV-2 seropositive compared to women whose sex partner did not travel. Having experienced genital lesions was also associated with HSV-2 infection ( value = 0.08). Conclusion. The 6.7% HSV-2 prevalence was similar to results obtained in studies among pregnant women in other parts of India. It appeared that most women in this study contracted HSV-2 from their spouses and few regularly used condoms. This finding highlights the need for public health policies to increase awareness and education about prevention methods among women and men living in rural India.
An estimated 536 million people aged 15–49 are infected with the herpes simplex virus type 2 (HSV-2) worldwide . HSV-2 is typically spread through sexual contact and results in a lifelong infection. The predominant symptom of the disease is genital lesions, but a majority of infected individuals experience no symptoms or mild ones that are often unrecognized . The high rate of asymptomatic cases enhances HSV-2 transmission because asymptomatic individuals shed the virus and transmit the disease .
Pregnant women are particularly vulnerable to the adverse sequelae of HSV-2 infection . HSV-2 infection in pregnancy has been associated with premature delivery, low birthweight infants, fetal malformations, and vertical transmission of the virus during childbirth [4, 5]. While neonatal herpes occurs in less than 1% of prevalent infections, the risk of transmission increases to 25–50% among women infected during pregnancy [6, 7]. In addition, it is estimated that prevalent HSV-2 infection is associated with a 2- to 4-fold increased risk of HIV-1 acquisition .
The seroprevalence of HSV-2 varies by region, country, and population . Various studies have estimated that about 40% of pregnant women in sub-Saharan Africa, 30% in Latin America, 17–22% in North America, and 4 to 24% in Europe are HSV-2 infected [8, 10–12]. An analysis of prevalence by country shows even greater heterogeneity. Studies from Sweden, Italy, Switzerland, and China show the HSV-2 prevalence in antenatal cases of 10.4%, 7.6%, 20.7%, and 10.8%, respectively [10, 13–15].
There are few studies describing HSV-2 prevalence among pregnant women in India. One cross-sectional study conducted among 1,640 pregnant women attending antenatal clinics in Arunachal Pradesh, Assam, Manipur, Meghalaya, and Mizoram (all states are located in the northeast of India) found overall HSV-2 seroprevalence of 8.7% with states ranging from a high of percentage 15% in Arunachal Pradesh to a low percentage of 2.7% in Manipur . Another study of asymptomatic pregnant females attending the Obstetrics and Gynecology Outpatient Department for a routine antenatal checkup in the North Indian State of Jammu found HSV-2 prevalence of 7.5% .
With one antenatal study from Tamil Nadu, a southern state in India, and limited seroprevalence estimates from other parts of the country, there is a great need for additional studies among pregnant women . The research describes the prevalence and determinants of HSV-2 infection among pregnant women living in rural villages in Mysore Taluk, Karnataka, India.
Public Health Research Institute of India (PHRII) is a nonprofit organization based in Mysore, India. PHRII operates a health clinic in Mysore providing free reproductive healthcare to women. PHRII maintains a public health laboratory and conducts mobile health clinics offering integrated antenatal care and HIV testing services in villages in Mysore Taluk for pregnant women. Mysore Taluk is located in the southern part of the state of Karnataka, India.
2.2. Study Population
Pregnant women living in rural villages located in Mysore Taluk were enrolled in the study from January to September 2009. Pregnant women in the villages were recruited through extensive community outreach and with the assistance of community and local health professionals. A total of 487 women from 52 villages submitted blood samples to be tested for HSV-2 and HIV. The Institutional Review Boards at the University of California, Berkeley, and Public Health Research Institute of India approved the study protocol.
2.3. Study Design
A list of the 141 villages in Mysore Taluk was obtained through the 2001 Indian Census and 52 villages were randomly selected to participate in an intervention providing integrated antenatal care and HIV testing using mobile medical clinics. Prior to the health camp, an outreach team met with village leaders and local health professionals to seek permission to work in the community. The team also met with the national rural health mission workers—the auxiliary nurse midwife (ANM), the accredited social health activist (ASHA), Anganwadi teacher and helper to discuss the program. The Anganwadi teacher provided a list of registered pregnant women in each of the villages and assisted in referring these women to the health clinic. Mobile health clinics were typically conducted in primary schools or community halls located in each village one day after a community-wide education and awareness program was conducted on the importance of antenatal care and institutional deliveries. Pregnant women were offered a free antenatal screening including clinical examination and laboratory evaluation and completed an interviewer-administered questionnaire.
2.4. Interview and Counseling
All pregnant women who came to the mobile medical clinic were offered pretest counseling in groups in the local language of Kannada. Each woman was then directed to a private space where she could discuss and ask any questions or clarifications before proceeding further through the program. Then, a trained female interviewer used a standardized questionnaire to collect information on sociodemographic status, work experience and economic status, knowledge about HIV/AIDS, sexual history, information on main sex partners, history of sexually transmitted infections, and HIV test reports. All women were assured of confidentiality of their responses.
2.5. Diagnostic Testing
After completion of an examination by the physician, a trained nurse collected blood samples from consenting participants to screen for HSV-2, HIV, and other routine antenatal investigations. Diagnostic tests were performed in the PHRII laboratory in Mysore. A type-specific ELISA was used to detect HSV-2 IgG antibodies in sera (Focus Technologies, Cypress, CA, USA). Tests were performed following manufacturer instructions using index values > 1.1 to define positive results. A blinded panel of 20 serum samples provided by St. John’s Medical College Research Institute, Bangalore, was used to validate testing and results were in agreement with 20 out of 20 samples. The first 89 samples were run in duplicate and all results were successfully replicated. In addition, all positive test results were duplicated to provide confirmation. HIV testing was performed using ELISA following manufacturer instructions (HIVASE 1 + 2, General Biologicals Corporation, Taiwan). All HIV testing was performed in duplicate. Any woman who was found to be infected with HIV was provided medications for prevention of vertical transmission of HIV and referred to the antiretroviral therapy center in KR Hospital. All women were subsequently followed up after delivery up to a period of two years.
2.6. Statistical Analysis
Data were analyzed using Stata 10.1 (Stata Corporation, College Station, TX). Pearson’s chi-square test adjusted to account for the cluster survey design was used to assess association of clinical characteristics and HSV-2 status using a value cutoff of 0.1 for significance . To obtain odds ratios, data were modeled using logistic regression, with HSV-2 status as the binary outcome of interest. In addition, relative risks were obtained using a generalized linear model with a log link function and binomial distribution. A cluster survey design was used because pregnant women were geographically grouped into villages; thus robust variance estimates adjusted within village correlation were obtained .
Most of the pregnant women in the selected villages participated in the program. Only 21 pregnant women in the community did not provide a blood sample, either because they had only recently done their antenatal investigations () or they declined to attend the medical clinic for personal reasons (). Of the 487 (95.6%) pregnant women tested for HSV-2 antibodies, 32 tested positive, giving a prevalence of 6.6%. Accounting for the cluster design of the sampling gives a prevalence of 6.7% (95% confidence interval (CI): 4.4–9.0). Of these 487 women, only one woman (0.2%) tested positive for human immunodeficiency virus antibodies.
Of the 487 women who provided a blood sample, 478 (98%) agreed to be interviewed, which included all women who tested positive for HSV-2. Characteristics of the study population are shown in Table 1. The median age of the study population was 20 years, ranging from 15 to 33 years of age. Education level varied, with 13% of women reporting completion of less than one year of education, while 33% had completed 1–7 years, 36% had completed 8–10 years, and 18% had completed more than 10 years of school. All but one woman participating in the study were married, with 34% of women married for one year or less, 40% married between 1 and 3 years, and only 26% married for longer than three years. About half the women in the study had children (52%). The median household income per month was 3000 INR (1 USD = 45.9 INR), ranging from 0 to 40,000 INR per month, while only 2.7% (13/478) of participants reported regularly earning income themselves. Almost all of the participants (99.2%, 473/477) in the study population reported a single sex partner in their lifetime and 88.7% (422/476) of study participants reported never using a condom with their main sex partner.
The majority of participants who tested positive for HSV-2 did not report symptoms commonly associated with HSV-2 (Table 2). Vaginal sores were experienced by 4% of the women in the study, while 21% reported experiencing painful urination and 13% reported having abnormal vaginal discharge. Evidence of an association was found for the presence of vaginal sores ( value = 0.08), with 9% of HSV-2 seropositive women reporting vaginal sores compared to 3% of HSV-2 seronegative women. Painful urination ( value = 0.26) and abnormal vaginal discharge ( value = 0.49) were not associated with HSV-2 status.
Using logistic regression, the unadjusted odds ratio was determined for each characteristic (Table 3). The only characteristic that showed evidence of affecting the odds of HSV-2 infection was if the sex partner ever traveled away from home, where participants whose partner ever traveled had 2.68 times the odds of being HSV-2 positive as compared to participants whose partner never traveled (95% CI: 1.14–6.34). A generalized linear model estimated the relative risk of HSV-2 among women whose partners ever traveled to be 2.44 (95% CI: 1.16–5.14) times greater than the probability of women whose husbands never traveled.
To control for possible confounding, multivariable logistic regression was used to adjust for the participant’s age and husband’s education level. In this model, women whose main sex partner ever traveled away from home had 2.77 (95% CI: 1.20–6.41) times the odds of having a prevalent HSV-2 infection.
This study found HSV-2 prevalence of 6.7% among pregnant women attending mobile antenatal care clinics in 52 rural villages located in Mysore Taluk, Karnataka, India. This is comparable to previously obtained measures of HSV-2 prevalence among other pregnant women in India [16, 17]. The 6.7% prevalence is lower than the three previously obtained estimates of HSV-2 prevalence in the state of Karnataka, which ranged from 10.9 to 18.9% [20–22] although these studies focused on nonpregnant populations.
Almost all the women in this study reported having a single sex partner in their lifetime and one woman reported being unmarried. It appears that the main route of HSV-2 transmission in this population is through sexual transmission from their spouses. Since very few married women consistently use a condom, the risk behavior of their husbands is a primary risk factor. This information highlights the need to increase awareness and discuss risk behaviors among both men and women living in rural India.
In our exploratory analysis, only having a husband who traveled away from home was significantly associated with an increased risk of HSV-2 infection. values were not adjusted for multiple comparisons. Misclassification should not have affected this finding since women would know how often their husbands traveled and there is no social stigma attached to this activity. In addition, living in a small rural village may present limited opportunity for sex outside of marriage, so only husbands who travel may have access to other sex partners. Furthermore, this may be the main entry point for HSV-2 into rural communities since sex workers are more common in urban areas and have been shown to have high rates of HSV-2 infection .
It is possible that this study overestimated the prevalence of HSV-2 in this population. There is a debate about the accuracy of the Focus Diagnostics HerpeSelect HSV-2 IgG ELISA test kits used in this study. Some researchers have suggested that the cutoff value for a positive test should be raised from 1.1 to 3.0 or 3.5 when the test is used in low prevalence settings [24, 25]. Raising the cutoff value to 3.5 would have affected the study results since 14 of the 32 positive tests fell in the disputed range, decreasing the estimated prevalence from 6.6% to 4.7%. Additional HSV-2 studies should be conducted using a gold standard like western blot to confirm the results.
In this study, the majority of HSV-2 positive individuals did not report experiencing symptoms caused by HSV-2. This is consistent with previous findings that HSV-2 is frequently asymptomatic or symptoms go unrecognized. We did find an association between the presence of vaginal sores and HSV-2 ( value = 0.08). However, only 9.4% of HSV-2 positive women reported experiencing vaginal sores, highlighting the challenge of diagnosing HSV-2 and the ability of HSV-2 to circulate undetected in a population.
There are several limitations to the study. Information about spouses was obtained from participants who were likely to possess incomplete knowledge of their partners’ behaviors, resulting in misclassification. There is the possibility of social desirability bias. Though interviews were conducted in a private setting and women were guaranteed anonymity, it is possible that participants still feared disclosing personally or socially sensitive information. This may also have resulted in misclassification that biased the results toward finding no association between certain risk behaviors. This study was limited by a small sample size and a low prevalence of HSV-2 in the study population limiting the power of the study to detect associations between personal characteristics and HSV-2. Associations found in other studies between older age and alcohol consumption and increased risk for HSV-2 infection were not found to be statistically significant in this study. It is possible that with a larger sample size, associations would be found between additional factors and increased risk of HSV-2 infection.
This study provides needed information regarding the prevalence of HSV-2 among rural pregnant women in India and will serve as an important baseline measurement as investigators continue to monitor rates of HSV-2 in the future in rural India.
Conflict of Interests
The authors declare no conflict of interests.
Dr. Madhivanan has full access to all data in the study and takes responsibility for the integrity of the data and accuracy of the data analysis. Study concept and design was done by Madhivanan, Arun, Krupp, and Klausner. Acquisition of data was done by Bochner, Niranjankumar, Ravi, and Arun. Analysis and interpretation of data was done by Bochner, Madhivanan, and Krupp. Drafting of the manuscript was done by Bochner and Madhivanan. Critical revision of the paper for important intellectual content was done by Bochner, Madhivanan, Niranjankumar, Ravi, Arun, Krupp, and Klausner.
For their generous assistance with this project, the authors would like to thank the PHRII staff for all their efforts in data collection and all the women in the study for their participation. Authors are grateful to Focus Technologies (Cypress, CA, USA) for donating HerpeSelect ELISA kits. This study was funded by the Elizabeth Glaser Pediatrics AIDS Foundation (EGPAF), International Leadership Award to Purnima Madhivanan. The funder had no role in the study design, conduct, collection, management, analysis, or interpretation of the data, preparation, review, or approval of the paper.
- K. J. Looker, G. P. Garnett, and G. P. Schmid, “An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection,” Bulletin of the World Health Organization, vol. 86, no. 10, pp. 805–812, 2008.
- L. Corey and H. H. Handsfield, “Genital herpes and public health: addressing a global problem,” Journal of the American Medical Association, vol. 283, no. 6, pp. 791–794, 2000.
- S. L. Sacks, P. D. Griffiths, L. Corey et al., “HSV shedding,” Antiviral Research, vol. 63, no. 1, pp. S19–S26, 2004.
- G. Straface, A. Selmin, V. Zanardo, M. De Santis, A. Ercoli, and G. Scambia, “Herpes simplex virus infection in pregnancy,” Infectious Diseases in Obstetrics and Gynecology, vol. 2012, Article ID 385697, 6 pages, 2012.
- Z. A. Brown, J. Benedetti, S. Selke, R. Ashley, D. H. Watts, and L. Corey, “Asymptomatic maternal shedding of herpes simplex virus at the onset of labor: relationship to preterm labor,” Obstetrics and Gynecology, vol. 87, no. 4, pp. 483–488, 1996.
- R. Whitley, “Neonatal herpes simplex virus infection,” Current Opinion in Infectious Diseases, vol. 17, no. 3, pp. 243–246, 2004.
- L. Corey and A. Wald, “Maternal and neonatal herpes simplex virus infections,” New England Journal of Medicine, vol. 361, no. 14, pp. 1328–1385, 2009.
- L. Corey, A. Wald, C. L. Celum, and T. C. Quinn, “The Effects of Herpes Simplex Virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics,” Journal of Acquired Immune Deficiency Syndromes, vol. 35, no. 5, pp. 435–445, 2004.
- M. Howard, J. W. Sellors, D. Jang et al., “Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada,” Journal of Clinical Microbiology, vol. 41, no. 1, pp. 84–89, 2003.
- E. Anzivino, D. Fioriti, M. Mischitelli et al., “Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention,” Virology Journal, vol. 6, article 40, 2009.
- R. G. Pebody, N. Andrews, D. Brown et al., “The seroepidemiology of herpes simplex virus type 1 and 2 in Europe,” Sexually Transmitted Infections, vol. 80, no. 3, pp. 185–191, 2004.
- D. M. Patrick, M. Dawar, D. A. Cook, M. Krajden, H. C. Ng, and M. L. Rekart, “Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in canadian women: HSV-2 prevalence increases throughout the reproductive years,” Sexually Transmitted Diseases, vol. 28, no. 7, pp. 424–428, 2001.
- M. Berntsson, P. Tunbäck, A. Ellström, I. Krantz, and G.-B. Löwhagen, “Decreasing prevalence of herpes simplex virus-2 antibodies in selected groups of women in Sweden,” Acta Dermato-Venereologica, vol. 89, no. 6, pp. 623–626, 2009.
- G. Enders, B. Risse, M. Zauke, I. Bolley, and F. Knotek, “Seroprevalence study of herpes simplex virus type 2 among pregnant women in Germany using a type-specific enzyme immunoassay,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 17, no. 12, pp. 870–872, 1998.
- X.-S. Chen, Y.-P. Yin, L.-P. Chen et al., “Herpes simplex virus 2 infection in women attending an antenatal clinic in Fuzhou, China,” Sexually Transmitted Infections, vol. 83, no. 5, pp. 369–370, 2007.
- D. Biswas, B. Borkakoty, J. Mahanta et al., “Seroprevalence and risk factors of herpes simplex virus type-2 infection among pregnant women in Northeast India,” BMC Infectious Diseases, vol. 11, article 325, 2011.
- S. Rathore, A. Jamwal, and V. Gupta, “Herpes simplex virus type 2: seroprevalence in antenatal women,” Indian Journal of Sexually Transmitted Diseases, vol. 31, no. 1, pp. 11–15, 2010.
- F. M. Cowan, R. S. French, P. Mayaud et al., “Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka,” Sexually Transmitted Infections, vol. 79, no. 4, pp. 286–290, 2003.
- StataCorp, Stata: Release 11. Statistical Software College Station, TX: StataCorp LP, 2009.
- M. L. Becker, B. M. Ramesh, R. G. Washington, S. Halli, J. F. Blanchard, and S. Moses, “Prevalence and determinants of HIV infection in South India: a heterogeneous, rural epidemic,” AIDS, vol. 21, no. 6, pp. 739–747, 2007.
- H. L. Munro, B. S. Pradeep, A. Ayyanat Jayachandran et al., “Prevalence and determinants of HIV and sexually transmitted infections in a general population-based sample in Mysore district, Karnataka state, southern India,” AIDS, vol. 22, no. 5, pp. S117–S125, 2008.
- P. Madhivanan, K. Krupp, V. Chandrasekaran et al., “Prevalence and correlates of bacterial vaginosis among young women of reproductive age in Mysore, India,” Indian Journal of Medical Microbiology, vol. 26, no. 2, pp. 132–137, 2008.
- M. Shahmanesh, F. Cowan, S. Wayal, A. Copas, V. Patel, and D. Mabey, “The burden and determinants of HIV and sexually transmitted infections in a population-based sample of female sex workers in Goa, India,” Sexually Transmitted Infections, vol. 85, no. 1, pp. 50–59, 2009.
- H. D. Mark, J. P. Nanda, J. Roberts, A. Rompalo, J. H. Melendez, and J. Zenilman, “Performance of focus ELISA tests for HSV-1 and HSV-2 antibodies among university students with no history of genital herpes,” Sexually Transmitted Diseases, vol. 34, no. 9, pp. 681–685, 2007.
- R. Ashley-Morrow, J. Nollkamper, N. J. Robinson, N. Bishop, and J. Smith, “Performance of Focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations,” Clinical Microbiology and Infection, vol. 10, no. 6, pp. 530–536, 2004.